Home
Cellex

Cellex Market Share Analysis for May 2026

Cellex Overview ➔ leading CDMO in cell therapy, partnering with pharma and biotech to ensure GMP-compliant CAR-T production, clinical trials, & consulting

Industry: N/A

Domaincellex.me

Year Founded2001

Employees201 - 500

Annual Revenue$2M - $5M

Cellex

Cellex (including company regionals)

cellex.me

See more website traffic and engagement information

Cellex Revenue up to May 2026 is 2M - 5M

revenue generated by Cellex top domains

Cellex top domains revenue over 3 years

Revenue for Cellex top domains

cellex.me2M - 5M

See more with Sales Intelligence

Total visits to Cellex's top domains

Understand Cellex market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

cellex.me2.3K

See more with Sales Intelligence

Avg. visit duration in Cellex's top domains

Analyze Cellex engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

cellex.me00:00:12

See more with Sales Intelligence

Avg. pageviews on Cellex's top domains

See how Cellex keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

cellex.me1.38

See more with Sales Intelligence

Cellex top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Cellex

These are the website technologies, by industry, used by Cellex top domains

Payment & Currencies (5)

Euro

Content Management System (3)

WordPress

Advertising (2)

DoubleClick

Conversion & Analytics (2)

Google Analytics

More Technologies

9

See all

News & Signals from Cellex

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSwarm Oncology Ltd. partners with Cellex Gmbh.Swarm Oncology Ltd., a biotechnology company, has partnered with Cellex Cell Professionals GmbH, a contract development and manufacturing organization (CDMO) specializing in cell and gene therapy (CGT) manufacturing, to accelerate the development and manufacturing of its T cell therapies for advanced solid cancers.

NewsCellex Gmbh launches CAR-T biotech aimed at developing chimeric antigen receptor T-cell therapies.Intellia Therapeutics, Blackstone, and Cellex have launched a CAR-T biotech aimed at developing chimeric antigen receptor (CAR) T-cell therapies.

NewsGemoab partners with Cellex Gmbh.GEMoaB has established a preferred partnership with its sister company Cellex, a world leader in manufacturing hematopoietic blood stem cell products and a leading European CMO for CAR-T cells, co-operating in that area with several large biotech companies.